Zenas BioPharma, Inc. Common Stock (ZBIO) — Cash Flow Reinvestment Rate
Latest as of September 2023:
0.00x
Zenas BioPharma, Inc. Common Stock (ZBIO) has a Cash Flow Reinvestment Rate of 0.00x as of September 2023, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $31.85 Million. Check ZBIO cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
$0.00
Capex + Investments
Operating Cash Flow
$31.85 Million
USD
Capital Expenditures
$0.00
USD
Annual Cash Flow Reinvestment Rate for Zenas BioPharma, Inc. Common Stock (None–None)
Year-by-year capital reinvestment analysis for Zenas BioPharma, Inc. Common Stock. For live market cap and broader valuation context, see market value of Zenas BioPharma, Inc. Common Stock.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow